Latest Prostate-specific antigen Stories
Final analysis of Phase 3 COU-AA-302 study presented at the European Society for Medical Oncology (ESMO) 2014 Congress HORSHAM, Pa., Sept.
-- Free Or Low Cost Screenings Help To Diagnose Second Leading Cause of Death Among Men Which Can Be Easily Treated If Caught Early -- DENVER, Sept.
Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept.
Proprietary genomic-based VPAC1 cancer biomarker to be co-developed worldwide? PARK CITY, Utah, Sept. 17, 2014 /PRNewswire/ -- NuView Life Sciences, Inc.
SANTA MONICA, Calif., Sept.
SAN ANTONIO, Sept. 9, 2014 /PRNewswire/ -- GenSpera, Inc.
Additional Data Acceptances Include Multiple Oncotype DX® Studies in Breast and Renal Cancers REDWOOD CITY, Calif., Sept. 9, 2014 /PRNewswire/ -- Genomic Health, Inc.
Prostate Cancer Awareness Month in September Promotes Importance of Early Detection to Save Men's Lives MELVILLE, N.Y., Sept.
LUGPA and ZERO Urge Men to Man Up and Go to the Doctor WASHINGTON, Sept.